Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Fingolimod treatment in multiple sclerosis leads to increased macular volume.
Oral BG-12 in multiple sclerosis.
Nitrous oxide induced myeloneuropathy: a case report.
Mitochondrial changes within axons in multiple sclerosis: an update.
Letter to the Editor.
[Biomarkers in neuromyelitis optica].
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.
Origin and differentiation of microglia.
Tumefactive demyelination: an approach to diagnosis and management.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
Clinical application of susceptibility weighted imaging: exploring from routine service.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
The nervous system's potential role in multiple sclerosis associated bone loss.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
Unilateral thalamic deep brain stimulation for disabling kinetic tremor in multiple sclerosis.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
Postpartum complicated by transverse myelitis.
Pages
« first
‹ previous
…
197
198
199
200
201
202
203
204
205
…
next ›
last »